Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosum.
Clin Exp Dermatol
; 37(2): 146-8, 2012 Mar.
Article
in En
| MEDLINE
| ID: mdl-22103549
ABSTRACT
Pyoderma gangrenosum (PG) may be associated with inflammatory disorders and haematological conditions such as monoclonal gammopathy of uncertain significance (MGUS). We report the case of a 53-year old man who had PG and MGUS. After treatment with infliximab for the PG, he developed myeloma. The course of events in this case suggests that infliximab facilitated the progression from MGUS to myeloma.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulin A
/
Tumor Necrosis Factor-alpha
/
Pyoderma Gangrenosum
/
Hypergammaglobulinemia
/
Anti-Inflammatory Agents
/
Antibodies, Monoclonal
/
Multiple Myeloma
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Dermatol
Year:
2012
Document type:
Article